- Home
- UTL vs MDXG Comparison
UTL vs MDXG Comparison
Compare UTL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UTL | MDXG |
|---|---|---|
| Founded | 1984 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 906.0M | 1.0B |
| IPO Year | 1995 | 2007 |
Fundamental Metrics
Financial Performance| Metric | UTL | MDXG |
|---|---|---|
| Price | $50.84 | $4.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 98.0K | ★ 780.8K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | 1.37 | ★ 14.29 |
| EPS | ★ 2.97 | 0.32 |
| Revenue | ★ $536,000,000.00 | $418,630,000.00 |
| Revenue This Year | $7.93 | N/A |
| Revenue Next Year | $5.85 | $13.14 |
| P/E Ratio | $17.49 | ★ $13.03 |
| Revenue Growth | 8.33 | ★ 19.99 |
| 52 Week Low | $45.11 | $4.12 |
| 52 Week High | $59.99 | $8.12 |
Technical Indicators
Market Signals| Indicator | UTL | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 24.51 |
| Support Level | $49.13 | N/A |
| Resistance Level | $53.19 | $5.38 |
| Average True Range (ATR) | 1.20 | 0.16 |
| MACD | -0.24 | -0.02 |
| Stochastic Oscillator | 9.21 | 13.29 |
Price Performance
Historical ComparisonAbout UTL UNITIL Corporation
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.